HIA
NBIX icon

Harbor Investment Advisory’s Neurocrine Biosciences NBIX Stock Holding History

Harbor Investment Advisory’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Buy
+660
New +$97.9K 0.01% 531
2024
Q2 		– Sell
-11
Closed -$1.52K – 1392
2024
Q1 		$1.52K Buy
+11
New +$1.5K ﹤0.01% 1164

Other funds holding NBIX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PBBUPS
PKO BP Bankowy Universal Pension Society Warsaw, Poland $350M AUM 272.18% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Harbor Investment Advisory's NBIX Position: Q2 2026 in Review

Harbor Investment Advisory opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 660 shares worth $111K. The stake represents 0.01% of the portfolio and ranks #531 among its holdings. This is a return to the name: Harbor Investment Advisory previously reported a position in NBIX as recently as Q1 2024.

Harbor Investment Advisory first reported a position in NBIX in Q1 2024 and has held it in 2 quarters since. 154 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Harbor Investment Advisory held 660 shares of Neurocrine Biosciences worth $111K as of Q2 2026.
  • Neurocrine Biosciences was a new Harbor Investment Advisory position in Q2 2026.
  • Neurocrine Biosciences made up 0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #531 holding.
  • Harbor Investment Advisory first reported a position in Neurocrine Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 154 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.